Cargando…

Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?

Detalles Bibliográficos
Autor principal:	Kang, Sokbom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549501/ https://www.ncbi.nlm.nih.gov/pubmed/23346307 http://dx.doi.org/10.3802/jgo.2013.24.1.1

Ejemplares similares

Vitamin D: more does not mean better
Publicado: (2020)

Comparing prediction models for lymph node metastasis risk in endometrial cancer: the winner may not take it all
por: Kang, Sokbom
Publicado: (2017)

Do we need a better marker for successful ovarian cancer surgery?
por: Kang, Sokbom
Publicado: (2017)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group
por: Chen, Yu-Li, et al.
Publicado: (2013)

The influence of rewards on incidental memory: more does not mean better
por: Cheng, Si, et al.
Publicado: (2020)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Coexisting Brenner Tumor and Endometrial Carcinoma
por: Sharma, Mitakshara, et al.
Publicado: (2017)

Better healthcare must mean better for patients and carers
por: de Iongh, Anya, et al.
Publicado: (2018)

Coexistence of Primary Umbilical Endometriosis and Endometrial Hyperplasia: A Case Report and Review of the Literature
por: Tilahun, Temesgen, et al.
Publicado: (2023)

Coexistence research requires more interdisciplinary communication
por: Hawlena, Hadas
Publicado: (2022)

Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
por: Zhao, Jie, et al.
Publicado: (2021)

Mortality risk prediction models: Methods of assessing discrimination and calibration and what they mean
por: Solomon, L J
Publicado: (2022)

More or Less the Same, but Better
Publicado: (1994)

What Does It Mean?
Publicado: (1901)

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women
por: Gbelcová, H., et al.
Publicado: (2015)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
por: Kim, Mi Kyoung, et al.
Publicado: (2014)

Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study
por: Prip, Clara M., et al.
Publicado: (2022)

Cervical adenocarcinoma in situ with negative conization margin: negligible or not?
por: Kang, Sokbom
Publicado: (2011)

LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
por: Kim, Mi Kyoung, et al.
Publicado: (2013)

Frequent Home Hemodialysis: More Is Better
por: Evans, Vanessa
Publicado: (2019)

Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study
por: Jeong, Jin Young, et al.
Publicado: (2020)

What Does Physiological Mean?
por: Petersen, Ole H
Publicado: (2023)

Does spatiotemporal nutrient variation allow more species to coexist?
por: Di Carvalho, Josie Antonucci, et al.
Publicado: (2020)

COPD: more treatment will translate to better breathing. Will it?
por: Teixeira, Paulo José Zimermann, et al.
Publicado: (2019)

Are aged pTreg cells “the more the better”?
por: Wang, Weikan, et al.
Publicado: (2022)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
por: Hui, Lee Shi, et al.
Publicado: (2021)

Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear
por: Ng, Joanna K. M., et al.
Publicado: (2023)

Association of the Apolipoprotein E 2 Allele with Concurrent Occurrence of Endometrial Hyperplasia and Endometrial Carcinoma
por: Ivanova, Tatiana I., et al.
Publicado: (2015)

What Does AI Mean to You?
por: Sorrell, Vincent L.
Publicado: (2022)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan
por: Lacey, J V, et al.
Publicado: (2008)

The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis
por: Kim, Bo Hyun
Publicado: (2018)

Need for more and better implementation science in global health
por: Ridde, Valéry
Publicado: (2016)

Caffeine and Bones: If Less Is Good, More May Not Be Better
por: Antonioli, Luca, et al.
Publicado: (2019)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
por: Giannella, Luca, et al.
Publicado: (2020)

Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?
por: Vibha, Deepti, et al.
Publicado: (2022)

A predictive model based on site-specific risk factors of recurrence regions in endometrial cancer patients
por: Shin, Wonkyo, et al.
Publicado: (2022)

Rapid sequence intubation: What does it mean? Does it really matter?
por: Tobias, Joseph D.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4j8j7ofrq89ltsqdb6klq1t7pi